A case of recurrence following comprehensive treatment for advanced gastric cancer with HER-2 amplification

被引：0
|
作者：
Zhou, Minghui [1 ,2 ]
Ye, Minfeng [2 ]
Chen, Jia [1 ,2 ]
Tao, Feng [2 ]
机构：
[1] Shaoxing Univ, Sch Med, Shaoxing 312000, Peoples R China
[2] Zhejiang Univ, Shaoxing Peoples Hosp, Shaoxing Hosp, Sch Med, Shaoxing 312000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 01期
关键词：
Gastric cancer; HER-2;
D O I：
10.1016/j.asjsur.2023.09.146
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：630 / 633
页数：4
相关论文
共 50 条
  • [41] HER2 Testing and Targeted Therapy in Advanced Gastric Cancer
    Hoehler, Thomas
    Rueschoff, Josef
    Ridwelski, Karsten
    Moehler, Markus
    ONKOLOGIE, 2010, 33 : 26 - 30
  • [42] Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer
    Rossi, Valentina
    Sarotto, Ivana
    Maggiorotto, Furio
    Berchialla, Paola
    Kubatzki, Franziska
    Tomasi, Nicoletta
    Redana, Stefania
    Martinello, Rossella
    Valabrega, Giorgio
    Aglietta, Massimo
    Ponzone, Riccardo
    Montemurro, Filippo
    ONCOLOGIST, 2012, 17 (11) : 1418 - 1425
  • [43] TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?
    Lamy, Pierre-Jean
    Jacot, William
    ONCOLOGIST, 2012, 17 (12) : E60 - E61
  • [44] Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancer
    Aisa, Adilai
    Weng, Shanshan
    Li, Xinyu
    Zhang, Ding
    Yuan, Ying
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180
  • [45] Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer
    Wu, Julie M.
    Halushka, Marc K.
    Argani, Pedram
    HUMAN PATHOLOGY, 2010, 41 (06) : 914 - 917
  • [46] Overexpression of Her-2 upregulates FoxM1 in gastric cancer
    Qi, Weiwei
    Li, Xiaoxiao
    Zhang, Yongchun
    Yao, Ruyong
    Qiu, Wensheng
    Tang, Dongfang
    Liang, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (06) : 1531 - 1538
  • [47] Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection
    Oh, Ho Suk
    Eom, Dae-Woon
    Kang, Gil Hyun
    Ahn, Yong Chel
    Lee, Sang Jin
    Kim, Ji-Hoon
    Jang, Hyuk Jai
    Kim, Eun Jung
    Oh, Kwang Hoon
    Ahn, Heui June
    GASTRIC CANCER, 2014, 17 (03) : 402 - 411
  • [48] Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection
    Ho Suk Oh
    Dae-Woon Eom
    Gil Hyun Kang
    Yong Chel Ahn
    Sang Jin Lee
    Ji-Hoon Kim
    Hyuk Jai Jang
    Eun Jung Kim
    Kwang Hoon Oh
    Heui June Ahn
    Gastric Cancer, 2014, 17 : 402 - 411
  • [49] Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer
    Han, Guohu
    Sun, Changchun
    Cui, Lihua
    Huang, Yufeng
    Yu, Lijiang
    Liu, Shenzha
    Tao, Min
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [50] HER-2 Expression and Response to Radiotherapy in Patients with Advanced Cervical Cancer
    Baiocchi, Glauco
    Begnami, Maria Dirlei
    Chen, Michael Jenwei
    Fukazawa, Elza Mieko
    Badiglian-Filho, Levon
    Assis Pellizzon, Antonio Cassio
    Soares, Fernando Augusto
    Lopes, Ademar
    JOURNAL OF REPRODUCTIVE MEDICINE, 2017, 62 (5-6) : 234 - 240
12345